A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.

Merck (MRK) announced that the European Commission has conditionally approved WELIREG, Merck’s oral hypoxia-inducible factor-2 alpha inhibitor, ...

The EC approval of these two indications is based on results from the LITESPARK-004 and LITESPARK-005 trials, respectively, ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

The results were impressive. PAC-MANN correctly identified pancreatic cancer in 98% of cases and was able to detect ...

The Brownsville community is mourning the death of Erasmo Castro. Castro reportedly passed Saturday morning, according to local officials. The well-known Brownsville native was serving as Brownsville ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...